Management of adverse events in TB care and active TB drug safety monitoring.

Tuberculosis (TB) remains the leading cause of death from a single infectious agent, with 10.8 million cases reported in 2023. While treatment is generally effective, both drug-susceptible (DS-TB) and drugresistant TB (DR-TB) regimens are associated with adverse events (AEs) that compromise adherenc...

Full description

Bibliographic Details

Published in:	Breathe Vol. 22; no. 1; pp. 1 - 11
Main Authors:	Ma'aruf, Shamsuddeen Yusuf, Sharma, Aparna, Fox, Shannon, Duarte, Raquel, Lange, Christoph, Tiberi, Simon
Format:	tables/charts Journal Article
Published:	European Respiratory Society Jan2026
Online Access:	View this record in EBSCOhost